Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) has appointed partner Jill Gatehouse as its new Tax practice group leader, effective 1 May. Gatehouse will succeed David Haworth, who has completed his term in the role.
Based in London, Gatehouse has been a partner in the firm’s tax practice since 2010 and a member of the firm’s Board since 2021. She brings experience working on high-profile international corporate transactions across multinational listed groups, private equity and real estate investors. Her work includes public and private M&A, equity and debt issuances, returns of capital, demergers, real estate investment and refinancing transactions.
Freshfields Senior partner Georgia Dawson commented: “I’m delighted to welcome Jill Gatehouse to the role of practice group leader for our global tax team. She brings significant experience to the position having provided complex tax advice across the most prominent international mandates. I look forward to supporting Jill in her strategic leadership of the practice. I also want to acknowledge the contribution from our outgoing head David Haworth, who has been a fantastic leader and played a vital role in developing the strategic growth of the practice.”
Freshfields’ Jill Gatehouse said: “I’m looking forward to taking on the leadership of the global tax practice and would like to take this opportunity to thank David for his commitment to the role and support during the transition. Our team of tax specialists are some of the industry’s leading experts, ensuring we support clients as they navigate fast-paced changes in tax policy and legislation, across borders. I look forward to working with the team to advance our ambitions in the tax space.”
Freshfields advises financial institutions, funds and corporate entities from all sectors on the tax issues arising on their most complex cross-border transactions, contentious tax matters and corporate tax policy issues. Notable recent client advisory work for the tax team included advising AmerisourceBergen on its acquisition of PharmaLex and Rentokil Initial on its $6.7 billion acquisition of Terminix.
